logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
J

Joshua Savage

cancer research uk
H指数:17
被引数:1,137

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Responses can be achieved with a combination of the MEK inhibitor selumetinib and dexamethasone in patients with relapsed/refractory RAS-pathway mutated acute lymphoblastic leukemia: Results of a parallel cohort, dose-finding and expansion phase I/II trial

联合使用MEK抑制剂塞鲁美替尼和地塞米松可在RAS通路突变的复发/难治性急性淋巴细胞白血病患者中实现应答：一项平行队列、剂量探索和扩展的I/II期试验结果

EJC Paediatric Oncology
IF0
2026-02-010
OAAI
Vormoor, Britta; Savage, Joshua; Kristunas, Caroline; Johnson, Sarah; Blanco, Mauricio Nicolas Ferrao; Shenton, Geoff; Lancaster, Donna; Castleton, Anna; Fielding, Adele K.; Latif, Anne-Louise; Morley, Nick; Strullu, Marion; Tuckuviene, Ruta; Kearns, Pamela; Jennings, Claire; Barnett, Shelby; Veal, Gareth J.; Irving, Julie; Billingham, Lucinda; Menne, Tobias; Vormoor, Josef
A randomised phase II trial of temozolomide with or without cannabinoids in patients with recurrent glioblastoma (ARISTOCRAT): protocol for a multi-centre, double-blind, placebo-controlled trial

替莫唑胺联合或不联合大麻素治疗复发性胶质母细胞瘤患者的随机II期试验 (ARISTOCRAT): 多中心、双盲、安慰剂对照试验方案

BMC CANCER
IF3.4
2024-01-158
OAAI
Bhaskaran, Divyalakshmi; Savage, Joshua; Patel, Amit; Collinson, Fiona; Mant, Rhys; Boele, Florien; Brazil, Lucy; Meade, Sara; Buckle, Peter; Lax, Sian; Billingham, Lucinda; Short, Susan C.

研究方向

暂未获取到该数据
L
Landon Trost
H 指数:40论文数:289被引数:5,040
T
Tobias Köhler
H 指数:32论文数:412被引数:4,640
L
L. Trost
H 指数:2论文数:74被引数:31
R
R Warner
H 指数:6论文数:41被引数:390
M
Matthew Ziegelmann
H 指数:28论文数:343被引数:2,855
M
M. Ziegelmann
H 指数:2论文数:109被引数:47
L
Lucinda Billingham
H 指数:48论文数:242被引数:8,381
S
Sevann Helo
H 指数:12论文数:221被引数:662
M
Mulham Alom
H 指数:3论文数:50被引数:59
K
Kiran Sharma
H 指数:24论文数:106被引数:1,994